| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | $14.4B | $8.4B |
| Cost of Revenue | $12.9B | $7.6B |
| Gross Profit | — | — |
| R&D Expense | — | — |
| SG&A Expense | $0.6B | $0.4B |
| Operating Income | $0.5B | $0.3B |
| Net Income | $0.1B | $-0.1B |
| EPS (Basic) | $0.27 | $-0.90 |
| EPS (Diluted) | $0.27 | $-0.90 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $11.5B | $12.0B |
| Current Assets | $3.1B | $3.1B |
| Cash & Equivalents | $0.4B | $0.5B |
| Total Liabilities | $6.8B | $7.4B |
| Current Liabilities | $2.4B | $2.0B |
| Stockholders' Equity | $4.5B | $4.5B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $0.5B | $0.0B |
| Investing Cash Flow | $0.2B | $0.5B |
| Capital Expenditures | $0.0B | $0.0B |
| Financing Cash Flow | $-0.8B | $-0.4B |